{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:07:50Z","timestamp":1790100470368,"version":"4.0.1"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018987","name":"Ministerul Cercet\u0103rii, Inov\u0103rii \u015fi Digitaliz\u0103rii","doi-asserted-by":"publisher","award":["760096"],"award-info":[{"award-number":["760096"]}],"id":[{"id":"10.13039\/100018987","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018987","name":"Ministerul Cercet\u0103rii, Inov\u0103rii \u015fi Digitaliz\u0103rii","doi-asserted-by":"publisher","award":["2302101"],"award-info":[{"award-number":["2302101"]}],"id":[{"id":"10.13039\/100018987","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101198470"],"award-info":[{"award-number":["101198470"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>The incidence of cancer continues to rise globally, with many tumor types remaining difficult to treat effectively. While existing drugs can alleviate symptoms or slow disease progression, their efficacy varies considerably between patients. To explore this challenge, we present a computational approach for identifying patient-specific candidate compounds. Our approach was developed for glioblastoma, but it can be applied to other types of cancer. Our study involves identifying possible disease-relevant proteins specific to each patient that underlie the generated networks, together with drug targets and proteins associated with cancer dependency. These networks are analyzed using centrality measures and Louvain community detection method. Then, further investigating the individual networks, network controllability analysis is applied to identify key regulatory targets within the network. These targets are filtered and ranked to prioritize candidate drugs for individualized treatment. By comparing results across patients and against networks based on generic data, we show substantial differences between patient-specific and generic network representations. Additionally, we track changes in patient-specific networks over time in five glioblastoma cases, exploring how molecular differences between primary and recurrent tumors may influence network structure and computational drug prioritization.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1014785","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:34:30Z","timestamp":1790098470000},"page":"e1014785","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["In-silico personalized protein\u2013protein interaction networks prioritize candidate compounds for glioblastoma"],"prefix":"10.1371","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9956-1718","authenticated-orcid":true,"given":"Nicoleta","family":"Siminea","sequence":"first","affiliation":[{"name":"University of Bucharest","place":["Bucharest, Romania"],"department":["Faculty of Mathematics and Computer Science"]},{"name":"Bioinformatics, National Institute of Research and Development for Biological Sciences","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor-Bogdan","family":"Popescu","sequence":"additional","affiliation":[{"name":"Revvity Inc.","place":["Turku, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"P\u0103un","sequence":"additional","affiliation":[{"name":"Bioinformatics, National Institute of Research and Development for Biological Sciences","place":["Bucharest, Romania"]},{"name":"University of Bucharest","place":["Bucharest, Romania"],"department":["Faculty of Business and Administration"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5014-5529","authenticated-orcid":true,"given":"Ion","family":"Petre","sequence":"additional","affiliation":[{"name":"Bioinformatics, National Institute of Research and Development for Biological Sciences","place":["Bucharest, Romania"]},{"name":"University of Turku","place":["Turku, Finland"],"department":["Department of Mathematics and Statistics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"P\u0103un","sequence":"additional","affiliation":[{"name":"University of Bucharest","place":["Bucharest, Romania"],"department":["Faculty of Mathematics and Computer Science"]},{"name":"Research Institute for Artificial Intelligence \u201cMihai Dr\u0103g\u0103nescu\u201d, Romanian Academy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"issue":"5","key":"pcbi.1014785.ref001","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002706","article-title":"Doctors\u2019 understanding of individualisation of drug treatments: a qualitative interview study","volume":"3","author":"S Denford","year":"2013","journal-title":"BMJ Open"},{"issue":"6","key":"pcbi.1014785.ref002","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg3493","article-title":"Molecular genetic testing and the future of clinical genomics","volume":"14","author":"SH Katsanis","year":"2013","journal-title":"Nat Rev Genet"},{"issue":"13","key":"pcbi.1014785.ref003","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/eurheartj\/ehs112","article-title":"Personalized medicine: hope or hype","volume":"33","author":"K Salari","year":"2012","journal-title":"Eur Heart J"},{"issue":"17","key":"pcbi.1014785.ref004","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"CS Karapetis","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"pcbi.1014785.ref005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1634\/theoncologist.9-2-116","article-title":"The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials","volume":"9","author":"S Martino","year":"2004","journal-title":"Oncologist"},{"issue":"8","key":"pcbi.1014785.ref006","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small-cell lung cancer","volume":"27","author":"M Wang","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"pcbi.1014785.ref007","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41582-019-0170-8","article-title":"Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis","volume":"15","author":"D Rotstein","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"pcbi.1014785.ref008","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cgh.2016.02.008","article-title":"Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer","volume":"14","author":"FA Sinicrope","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"pcbi.1014785.ref009","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41571-019-0299-9","article-title":"Towards personalized treatment for early stage HER2-positive breast cancer","volume":"17","author":"K Goutsouliak","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"pcbi.1014785.ref010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12874-018-0482-1","article-title":"DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network","volume":"18","author":"JL Katzman","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"pcbi.1014785.ref011","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab048","article-title":"DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration","volume":"22","author":"Y Wang","year":"2021","journal-title":"Brief Bioinform"},{"issue":"12","key":"pcbi.1014785.ref012","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae688","article-title":"DeepDR: a deep learning library for drug response prediction","volume":"40","author":"Z Jiang","year":"2024","journal-title":"Bioinformatics"},{"key":"pcbi.1014785.ref013","doi-asserted-by":"crossref","first-page":"035006","DOI":"10.1103\/RevModPhys.88.035006","article-title":"Control principles of complex systems","volume":"88","author":"YY Liu","year":"2016","journal-title":"Rev Mod Phys"},{"issue":"7","key":"pcbi.1014785.ref014","article-title":"Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients","volume":"49","author":"W-F Guo","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"5181","key":"pcbi.1014785.ref015","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1126\/science.8091226","article-title":"Genetic Dissection of Complex Traits","volume":"265","author":"ES Lander","year":"1994","journal-title":"Science"},{"issue":"9","key":"pcbi.1014785.ref016","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A New Initiative on Precision Medicine","volume":"372","author":"FS Collins","year":"2015","journal-title":"New England J Med"},{"issue":"1","key":"pcbi.1014785.ref017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrg2484","article-title":"RNA-Seq: a revolutionary tool for transcriptomics","volume":"10","author":"Z Wang","year":"2009","journal-title":"Nat Rev Genet"},{"issue":"11","key":"pcbi.1014785.ref018","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41576-019-0150-2","article-title":"RNA sequencing: the teenage years","volume":"20","author":"R Stark","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"7","key":"pcbi.1014785.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.1002195","article-title":"Big Data: Astronomical or Genomical?","volume":"13","author":"ZD Stephens","year":"2015","journal-title":"PLOS Biol"},{"issue":"2","key":"pcbi.1014785.ref020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrg1272","article-title":"Network biology: understanding the cell\u2019s functional organization","volume":"5","author":"A-L Barab\u00e1si","year":"2004","journal-title":"Nat Rev Genet"},{"key":"pcbi.1014785.ref021","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1752-0509-2-52","article-title":"A computational analysis of protein-protein interaction networks in neurodegenerative diseases","volume":"2","author":"J Go\u00f1i","year":"2008","journal-title":"BMC Syst Biol"},{"issue":"6224","key":"pcbi.1014785.ref022","doi-asserted-by":"crossref","first-page":"1257601","DOI":"10.1126\/science.1257601","article-title":"Disease networks. Uncovering disease-disease relationships through the incomplete interactome","volume":"347","author":"J Menche","year":"2015","journal-title":"Science"},{"issue":"18","key":"pcbi.1014785.ref023","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1073\/pnas.1603992113","article-title":"Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets","volume":"113","author":"A Vinayagam","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pcbi.1014785.ref024","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2105-8-224","article-title":"Characterization of protein-interaction networks in tumors","volume":"8","author":"A Platzer","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"pcbi.1014785.ref025","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12094-016-1497-x","article-title":"Survival in glioblastoma: a review on the impact of treatment modalities","volume":"18","author":"PD Delgado-L\u00f3pez","year":"2016","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"pcbi.1014785.ref026","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(17)30194-8","article-title":"European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas","volume":"18","author":"M Weller","year":"2017","journal-title":"Lancet Oncol"},{"issue":"2","key":"pcbi.1014785.ref027","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.critrevonc.2008.02.005","article-title":"Glioblastoma in adults","volume":"67","author":"AA Brandes","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"pcbi.1014785.ref028","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(17)30345-5","article-title":"European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma","volume":"18","author":"A Pace","year":"2017","journal-title":"Lancet Oncol"},{"issue":"8","key":"pcbi.1014785.ref029","article-title":"Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma","volume":"9","author":"YT Oh","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"pcbi.1014785.ref030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41698-022-00290-8","article-title":"A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironment","volume":"6","author":"RC Cornelison","year":"2022","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"pcbi.1014785.ref031","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56473-0","article-title":"Applied Precision Cancer Medicine in Neuro-Oncology","volume":"9","author":"H Taghizadeh","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"pcbi.1014785.ref032","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1007\/s00432-022-04050-w","article-title":"Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma","volume":"149","author":"L Lazaridis","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"pcbi.1014785.ref033","doi-asserted-by":"crossref","unstructured":"Tomczak K, Czerwi\u0144ska P, Wiznerowicz M. Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemporary Oncology\/Wsp\u00f3\u0142czesna Onkologia. 2015; p. 68\u201377.","DOI":"10.5114\/wo.2014.47136"},{"issue":"2","key":"pcbi.1014785.ref034","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.02.060","article-title":"Comprehensive Characterization of Cancer Driver Genes and Mutations","volume":"173","author":"MH Bailey","year":"2018","journal-title":"Cell"},{"issue":"1","key":"pcbi.1014785.ref035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"M Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"pcbi.1014785.ref036","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nmeth.4077","article-title":"OmniPath: guidelines and gateway for literature-curated signaling pathway resources","volume":"13","author":"D T\u00fcrei","year":"2016","journal-title":"Nat Methods"},{"key":"pcbi.1014785.ref037","article-title":"SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update","volume":"48","author":"L Licata","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1014785.ref038","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/nar\/gkg034","article-title":"STRING: a database of predicted functional associations between proteins","volume":"31","author":"C von Mering","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1014785.ref039","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks1147","article-title":"InnateDB: systems biology of innate immunity and beyond--recent updates and continuing curation","volume":"41","author":"K Breuer","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1014785.ref040","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"Consortium UniProt","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1014785.ref041","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"RGW Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"pcbi.1014785.ref042","article-title":"The Reactome Pathway Knowledgebase 2024","volume":"52","author":"M Milacic","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"pcbi.1014785.ref043","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a Cancer Dependency Map","volume":"170","author":"A Tsherniak","year":"2017","journal-title":"Cell"},{"key":"pcbi.1014785.ref044","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv1075","article-title":"The SIDER database of drugs and side effects","volume":"44","author":"M Kuhn","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1014785.ref045","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"DS Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1014785.ref046","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-Brain Barrier: From Physiology to Disease and Back","volume":"99","author":"MD Sweeney","year":"2019","journal-title":"Physiol Rev"},{"issue":"1","key":"pcbi.1014785.ref047","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/bdd.2331","article-title":"The role of the efflux transporter, P-glycoprotein, at the blood-brain barrier in drug discovery","volume":"44","author":"B Cox","year":"2023","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"pcbi.1014785.ref048","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bdd.2345","article-title":"Recent advances in the in vitro and in vivo methods to assess impact of P-glycoprotein and breast cancer resistance protein transporters in central nervous system drug disposition","volume":"44","author":"S Chatterjee","year":"2023","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"pcbi.1014785.ref049","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"D Wu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"pcbi.1014785.ref050","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"F Cheng","year":"2012","journal-title":"J Chem Inf Model"},{"key":"pcbi.1014785.ref051","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"A Daina","year":"2017","journal-title":"Sci Rep"},{"key":"pcbi.1014785.ref052","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"MV Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1014785.ref053","doi-asserted-by":"crossref","unstructured":"Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov Results Database \u2014 Update and Key Issues. New England Journal of Medicine. 2011;364(9):852\u201360. doi: 10.1056\/NEJMsa1012065","DOI":"10.1056\/NEJMsa1012065"},{"issue":"1","key":"pcbi.1014785.ref054","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"MD Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"1","key":"pcbi.1014785.ref055","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","article-title":"Network-based prediction of drug combinations","volume":"10","author":"F Cheng","year":"2019","journal-title":"Nat Commun"},{"key":"pcbi.1014785.ref056","doi-asserted-by":"crossref","DOI":"10.25080\/TCWV9851","article-title":"Exploring Network Structure, Dynamics, and Function using NetworkX","author":"AA Hagberg","year":"2008","journal-title":"Python Sci Conference"},{"issue":"10","key":"pcbi.1014785.ref057","doi-asserted-by":"crossref","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","article-title":"Fast unfolding of communities in large networks","volume":"2008","author":"VD Blondel","year":"2008","journal-title":"J Stat Mech"},{"key":"pcbi.1014785.ref058","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/ncomms6415","article-title":"Target control of complex networks","volume":"5","author":"J Gao","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"pcbi.1014785.ref059","doi-asserted-by":"crossref","first-page":"10327","DOI":"10.1038\/s41598-017-10491-y","article-title":"Controlling Directed Protein Interaction Networks in Cancer","volume":"7","author":"K Kanhaiya","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"pcbi.1014785.ref060","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab490","article-title":"Network analytics for drug repurposing in COVID-19","volume":"23","author":"N Siminea","year":"2021","journal-title":"Brief Bioinform"},{"issue":"1","key":"pcbi.1014785.ref061","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1038\/s41598-020-59717-6","article-title":"Controllability analysis of molecular pathways points to proteins that control the entire interaction network","volume":"10","author":"P Devkota","year":"2020","journal-title":"Sci Rep"},{"issue":"21","key":"pcbi.1014785.ref062","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1093\/bioinformatics\/btab570","article-title":"NetControl4BioMed: a web-based platform for controllability analysis of protein-protein interaction networks","volume":"37","author":"V-B Popescu","year":"2021","journal-title":"Bioinformatics"},{"issue":"1","key":"pcbi.1014785.ref063","article-title":"A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell lines","volume":"4","author":"AH Shah","year":"2021","journal-title":"Neurooncol Adv"},{"key":"pcbi.1014785.ref064","article-title":"PubChem 2025 update","volume":"53","author":"S Kim","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1014785.ref065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13321-020-00456-1","article-title":"An open source chemical structure curation pipeline using RDKit","volume":"12","author":"AP Bento","year":"2020","journal-title":"J Cheminform"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:34:46Z","timestamp":1790098486000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014785"}},"subtitle":[],"editor":[{"given":"Paolo","family":"Milazzo","sequence":"first","affiliation":[{"name":"University of Pisa: Universita degli Studi di Pisa","place":["ITALY"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1014785","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]}}}